Header Logo
Last Name

Kristina M Deligiannidis MD

TitleAdjunct Associate Professor
InstitutionUniversity of Massachusetts Medical School
AddressZucker Hillside Hospital- Kaufman Bldg
75-59 263rd Street, Suite 103
Glen Oaks NY 11004
vCardDownload vCard
    Other Positions
    InstitutionUMMS - School of Medicine

    Collapse ORNG Applications 
    Collapse Featured Videos

    Collapse Biography 
    Collapse education and training
    University of Massachusetts Amherst, Amherst, MA, United StatesBSBiology/ Psychology
    University of Massachusetts Medical School, Worcester, MA, United StatesMDMedicine
    Collapse awards and honors
    1996Summer Intramural Research Training Award;Developmental Endocrinology/Genetics/Neuroendocrinology, NIH/NICHD
    1997Commonwealth Scholar; Univ. of Massachusetts at Amherst
    1998 - 2000Predoctoral Intramural Research Training Award;Developmental Endocrinology/Genetics/Neuroendocrine, NIH/NICHD
    2003Medical Student Clinical Research Electives Program:Pediatrics & Developmental Neuropsychiatry , NIH/NICHD
    2003 - 2004Charles J. Hoff Scholar; UMass Medical School
    2004T. Byram Karasu Award in Psychotherapy for Medical Students
    2007 - 2008ASCP/NIMH Clinical Trials in Psychopharmacology Award
    2008 - 2009APA/APIRE Junior Investigator Awards
    2009Paul F. Briscoli Award for Resident-Faculty Academic Collaboration; UMass Medical School
    2009Resident Educator Award; UMass Medical School
    2009Resident Elective Program in Clinical Research; Experimental Therapeutics/Pathophysiology Branch, NIH/NIMH
    2009Resident Elective Program in Clinical Research; Behavioral Endocrinology Branch, NIH/NIMH
    2009ASCP/NCDEU/NIMH New Investigator Award
    2010Worcester Foundation for Biomedical Research Grant
    2011Society for Biological Psychiatry (SOBP) Travel Scholarship Award
    2011Career Development Research Fellowship Award; UMass Medical Dept. Psychiatry
    2011Faculty Scholar Award; UMass Medical School
    2011 - 2013NIH/UMass Medical CTSA Pilot Project Program Grant, NIH/NCATS
    2012Faculty Teaching Award for Outstanding Resident Teaching; UMass Medical School Dept. Psychiatry
    2012 - 2014Career Development Institute (CDI) for Psychiatry Award (NIMH R25) Univ. Pittsburgh/Stanford Univ., NIH/NIMH
    2013 - 2018NIH/NIMH K23 Career Development Award, NIH/NIMH
    2013Early Career Achievement in Science and Health Award; UMass Medical School
    2013Best Doctors in America
    2013National Network of Depression Centers (NNDC) Annual Scientific Conference Travel Award
    2014ACNP (American College of Neuropsychopharmacology) Travel Award
    2014 - 2016NIH/NIMH Clinical Research Loan Repayment Program Award, NIH/NIMH
    2014NIH Early Career Reviewer, Center for Scientific Review, NIH/CSR
    2016SOBP George N Thompson Award for Distinguished Service, SOBP
    2017Barbara Albinder Collaborative Women in Science Award ($5,000), Feinstein Institute for Medical Research (FIMR)
    2017 - 2019NIH Extramural Clinical Research Loan Repayment Program Contract Competitive Renewal Award
    2018Innovation Award ($10,000), Feinstein Institute for Medical Research (FIMR)
    2019Elected to Associate Member, American College of Neuropsychopharmacology (ACNP)
    2019Jennifer and Bradley Marsh Educational Advancement Award ($3,000), Feinstein Institute for Medical Research (FIMR)
    2019 Northwell Health's Truly Rising Star (Innovation) Award

    Collapse Overview 
    Collapse overview
    Dr. Deligiannidis completed her undergraduate degrees in Biology and Psychology at the University of Massachusetts at Amherst. As a recipient of pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH). Dr. Deligiannidis completed additional research training at the NIH during medical school and residency in behavioral endocrinology and experimental therapeutics at the National Institute of Mental Health (NIMH). She received her medical degree from, and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. After residency she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging. 
    Dr. Deligiannidis joined faculty at Zucker Hillside Hospital/Feinstein Institutes for Medical Research/Zucker School of Medicine at Hofstra/Northwell in September 2016 and is Board Certified by the American Board of Psychiatry and Neurology. Dr. Deligiannidis is the Director of Women's Behavioral Health at Zucker Hillside Hospital at Northwell Health. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle and pregnancy/postpartum periods. 
    Over the past ten years, Dr. Deligiannidis has been a leader in the field of perinatal depression and in novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in women's behavioral health. She has authored over 50 peer-reviewed articles plus several textbook chapters, has given over 70 oral presentations and presented over 100 research posters at scientific conferences. Dr. Deligiannidis has received federal, foundation and industry research funding, including prestigious NIH K23 and R01 grants. Her research efforts have been nationally recognized with many awards for research and for teaching of medical students and residents. Her research has been covered by major media outlets, including CNN, the Associated Press, National Public Radio, Boston Globe, Boston ABC News, Boston CBS News, CBS-New York, ABC-New York, Newsday and others.
    Dr. Deligiannidis actively contributes to national scientific committees and gives scientific presentations nationally and internationally. She is an Associate Member of the American College of Neuropsychopharmacology (ACNP), a member of the Society of Biological Psychiatry (SOBP), the American Society of Clinical Psychopharmacology (ASCP) and the Marcé Society of North America (perinatal mental health). She serves on the national ASCP Board of Directors, and the SOBP Council, as a reviewer on over 20 scientific journals and on the Advisory Board for the journal Acta Psychiatrica Scandinavica. She also serves as a member of the ACNP Committee on Education & Training and actively serves as a federal grant reviewer for the Center for Scientific Review at NIH. 
    Locally in metro NYC/Long Island, she serves on steering committees in both the Departments of Obstetrics & Gynecology and Psychiatry at Long Island Jewish Medical Center and Zucker Hillside Hospital and at the Katz Institute for Women's Health on Long Island. She additionally serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell. She is a sought-out educator and mentor to medical students, nurse practitioner students, residents, fellows and faculty across Northwell Health and at its Schools of Medicine and Nursing. She serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell.

    Collapse Rotation Projects

    Please contact Dr. Deligiannidis (kdeligian1@northwell.edu) to discuss research training/mentorship opportunities.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Carlini SV, Deligiannidis KM. Poor neonatal adaptation syndrome: Toward a clinical consensus to guide research and counseling. Acta Psychiatr Scand. 2021 Nov 24. PMID: 34817073.
      View in: PubMed
    2. Schoretsanitis G, Carlini SV, John M, Kane JM, Deligiannidis KM. Antenatal Antidepressant Prescription Associated With Reduced Fetal Femur Length but Not Estimated Fetal Weight: A Retrospective Ultrasonographic Study. J Clin Psychopharmacol. 2021 Aug 20. PMID: 34412105.
      View in: PubMed
    3. Weiss SJ, Flynn H, Christian L, Hantsoo L, di Scalea TL, Kornfield SL, Muzik M, Simeonova DI, Cooper BA, Strahm A, Deligiannidis KM. Symptom profiles of women at risk of mood disorders: A latent class analysis. J Affect Disord. 2021 Aug 12; 295:139-147. PMID: 34450523.
      View in: PubMed
    4. Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, Doherty J, Jonas J, Li S, Sankoh AJ, Silber C, Campbell AD, Werneburg B, Kanes SJ, Lasser R. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2021 Jun 30. PMID: 34190962.
      View in: PubMed
    5. Schoretsanitis G, Westin AA, Stingl JC, Deligiannidis KM, Paulzen M, Spigset O. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 21; 110228. PMID: 33358964.
      View in: PubMed
    6. Hare MM, Kroll-Desrosiers A, Deligiannidis KM. Peripartum depression: Does risk versus diagnostic status impact mother-infant bonding and perceived social support? Depress Anxiety. 2021 04; 38(4):390-399. PMID: 33615587.
      View in: PubMed
    7. Reinstein SA, Cosgrove J, Malekshahi T, Deligiannidis KM. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. J Clin Psychiatry. 2020 Nov 24; 81(6). PMID: 33238084.
      View in: PubMed
    8. Schoretsanitis G, Deligiannidis KM. Prenatal complications and neurodevelopmental outcomes in offspring: interactions and confounders. Acta Psychiatr Scand. 2020 Sep 21. PMID: 32956487.
      View in: PubMed
    9. Deligiannidis KM, Kroll-Desrosiers AR, Tan Y, Dubuke ML, Shaffer SA. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis. Psychoneuroendocrinology. 2020 Aug 13; 121:104827. PMID: 32828068.
      View in: PubMed
    10. Hermann A, Deligiannidis KM, Bergink V, Monk C, Fitelson EM, Robakis TK, Birndorf C. Response to SARS-Covid-19-related visitor restrictions on labor and delivery wards in New York City. Arch Womens Ment Health. 2020 Apr 15. PMID: 32296947.
      View in: PubMed
    11. Reinstein SA, Deligiannidis KM. Acute Bipolar Psychosis Limited to the Course of an Ectopic Pregnancy. Psychosomatics. 2020 Apr 12. PMID: 32402409.
      View in: PubMed
    12. Schoretsanitis G, Spigset O, Stingl JC, Deligiannidis KM, Paulzen M, Westin AA. The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis. Expert Opin Drug Metab Toxicol. 2020 Apr 02. PMID: 32238008.
      View in: PubMed
    13. Carlini SV, Deligiannidis KM. Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review. J Clin Psychiatry. 2020 Feb 04; 81(2). PMID: 32023366.
      View in: PubMed
    14. Schoretsanitis G, Westin AA, Deligiannidis KM, Spigset O, Paulzen M. Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: A systematic critical review and combined analysis. Ther Drug Monit. 2019 Aug 16. PMID: 31425493.
      View in: PubMed
    15. Frieder A, Fersh M, Hainline R, Deligiannidis KM. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development. CNS Drugs. 2019 Feb 21. PMID: 30790145.
      View in: PubMed
    16. Duan C, Hare MM, Staring M, Deligiannidis KM. Examining the relationship between perinatal depression and neurodevelopment in infants and children through structural and functional neuroimaging research. Int Rev Psychiatry. 2019 Jan 31; 1-16. PMID: 30701993.
      View in: PubMed
    17. Deligiannidis KM, Fales CL, Kroll-Desrosiers AR, Shaffer SA, Villamarin V, Tan Y, Hall JE, Frederick BB, Sikoglu EM, Edden RA, Rothschild AJ, Moore CM. Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic imaging and resonance study. Neuropsychopharmacology. 2018 Oct 17. PMID: 30327498.
      View in: PubMed
    18. Reza N, Deligiannidis KM, Eustis EH, Battle CL. Complementary Health Practices for Treating Perinatal Depression. Obstet Gynecol Clin North Am. 2018 Sep; 45(3):441-454. PMID: 30092920.
      View in: PubMed
    19. Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018 Aug 31. PMID: 30177236.
      View in: PubMed
    20. Buglione-Corbett R, Deligiannidis KM, Leung K, Zhang N, Lee M, Rosal MC, Moore Simas TA. Expression of inflammatory markers in women with perinatal depressive symptoms. Arch Womens Ment Health. 2018 Mar 30. PMID: 29603018.
      View in: PubMed
    21. Silver M, Moore CM, Villamarin V, Jaitly N, Hall JE, Rothschild AJ, Deligiannidis KM. White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study. Neuropsychopharmacology. 2018 Jun; 43(7):1573-1580. PMID: 29453442.
      View in: PubMed
    22. Tinkelman A, Hill EA, Deligiannidis KM. Management of New Onset Psychosis in the Postpartum Period. J Clin Psychiatry. 2017 Nov/Dec; 78(9):1423-1424. PMID: 29125722.
      View in: PubMed
    23. Duan C, Cosgrove J, Deligiannidis KM. Understanding Peripartum Depression Through Neuroimaging: a Review of Structural and Functional Connectivity and Molecular Imaging Research. Curr Psychiatry Rep. 2017 Aug 19; 19(10):70. PMID: 28823105.
      View in: PubMed
    24. Flynn HA, Spino C, Guille C, Deligiannidis KM, Maki P, Jahnke J, Rosenblum KL, Epperson CN, Weiss SJ. A Collaborative, Network-Based Approach to Advance Women's Depression Research in the United States: Preliminary Findings. J Womens Health (Larchmt). 2018 01; 27(1):51-57. PMID: 28727948.
      View in: PubMed
    25. Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017 Jun 12. PMID: 28619476.
      View in: PubMed
    26. Putnam KT, Wilcox M, Robertson-Blackmore E, Sharkey K, Bergink V, Munk-Olsen T, Deligiannidis KM, Payne J, Altemus M, Newport J, Apter G, Devouche E, Viktorin A, Magnusson P, Penninx B, Buist A, Bilszta J, O'Hara M, Stuart S, Brock R, Roza S, Tiemeier H, Guille C, Epperson CN, Kim D, Schmidt P, Martinez P, Di Florio A, Wisner KL, Stowe Z, Jones I, Sullivan PF, Rubinow D, Wildenhaus K, Meltzer-Brody S. Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. Lancet Psychiatry. 2017 May 03. PMID: 28476427.
      View in: PubMed
    27. Kroll-Desrosiers AR, Nephew BC, Babb JA, Guilarte-Walker Y, Moore Simas TA, Deligiannidis KM. Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year. Depress Anxiety. 2017 Feb; 34(2):137-146. PMID: 28133901.
      View in: PubMed
    28. Di Florio A, Putnam K, Altemus M, Apter G, Bergink V, Bilszta J, Brock R, Buist A, Deligiannidis KM, Devouche E, Epperson CN, Guille C, Kim D, Lichtenstein P, Magnusson PK, Martinez P, Munk-Olsen T, Newport J, Payne J, Penninx BW, O'Hara M, Robertson-Blackmore E, Roza SJ, Sharkey KM, Stuart S, Tiemeier H, Viktorin A, Schmidt PJ, Sullivan PF, Stowe ZN, Wisner KL, Jones I, Rubinow DR, Meltzer-Brody S. The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. Psychol Med. 2017 Apr; 47(5):787-799. PMID: 27866476.
      View in: PubMed
    29. Jun-O'Connell AH, Butala A, Morales IB, Henninger N, Deligiannidis KM, Byatt N, Ionete C. The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2016 Aug 19; appineuropsych15120403. PMID: 27539374.
      View in: PubMed
    30. Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA. Peripartum neuroactive steroid and ?-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology. 2016 Aug; 70:98-107. PMID: 27209438.
      View in: PubMed
    31. Weiss SJ, Muzik M, Deligiannidis KM, Ammerman RT, Guille C, Flynn HA. J Depress Anxiety. Gender differences in suicide risk factors among individuals with mood disorders. 2016; 218(5).
    32. Deligiannidis KM, Kroll-Desrosiers AR, Svenson A, Jaitly N, Barton BA, Hall JE, Rothschild AJ. Cortisol response to the Trier Social Stress Test in pregnant women at risk for postpartum depression. Arch Womens Ment Health. 2016 Oct; 19(5):789-97. PMID: 26951216.
      View in: PubMed
    33. Deligiannidis KM. The physician-scientist workforce in the United States. Acta Psychiatr Scand. 2015 Oct; 132(4):317-8. PMID: 25950491.
      View in: PubMed
    34. Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry. 2015 Jan; 2(1):59-67. PMID: 26359613.
      View in: PubMed
    35. Østergaard SD, Fava M, Rothschild AJ, Deligiannidis KM. The implications of the National Institute of Mental Health Research Domain Criteria for researchers and clinicians. Acta Psychiatr Scand. 2014 Dec; 130(6):409-14. PMID: 25201294.
      View in: PubMed
    36. Babb JA, Deligiannidis KM, Murgatroyd CA, Nephew BC. Peripartum depression and anxiety as an integrative cross domain target for psychiatric preventative measures. Behav Brain Res. 2015 Jan 1; 276:32-44. PMID: 24709228.
      View in: PubMed
    37. Deligiannidis KM, Byatt N, Freeman MP. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 2014 Apr; 34(2):244-55. PMID: 24525634.
      View in: PubMed
    38. Smith EG, Deligiannidis KM, Ulbricht CM, Landolin CS, Patel JK, Rothschild AJ. Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2013 Oct; 74(10):966-73. PMID: 24229746.
      View in: PubMed
    39. Deligiannidis KM, Rothschild AJ, Barton BA, Kroll-Desrosiers AR, Meyers BS, Flint AJ, Whyte EM, Mulsant BH. A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. J Clin Psychiatry. 2013 Oct; 74(10):1003-9. PMID: 24229753.
      View in: PubMed
    40. Deligiannidis KM, Freeman MP. Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol. 2014 Jan; 28(1):85-95. PMID: 24041861.
      View in: PubMed
    41. Deligiannidis KM, Sikoglu EM, Shaffer SA, Frederick B, Svenson AE, Kopoyan A, Kosma CA, Rothschild AJ, Moore CM. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res. 2013 Jun; 47(6):816-28. PMID: 23499388.
      View in: PubMed
    42. Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013 Feb; 127(2):94-114. PMID: 23240634.
      View in: PubMed
    43. Deligiannidis KM, Girgis RR, Lau A, Balon R, Zisook S. Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major depression. Acad Psychiatry. 2012 Sep 1; 36(5):414-8. PMID: 22983477.
      View in: PubMed
    44. Moore Simas T, Byatt N, Deligiannidis KM. Alternative and Complementary Therapies. Clinical Roundup: How do you treat premenstrual syndrome in your practice?. 2011; 17(4):237.
    45. Deligiannidis KM. Psychiatry Issue Briefs. Depression in women during childbearing years: causes, symptoms, challenges and treatment. 2011; 8(1).
    46. Prabhakar D, Balon R, Deligiannidis, KM, Zisook S. . Revista de Trastornos del Ánimo. The American Society for Clinical Psychopharmacology’s Modules in Depression and Bipolar Disorder: Answering the Call for a Model Curriculum. 2011; 1(7):8-13.
    47. Deligiannidis KM, Freeman MP. Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin North Am. 2010 Jun; 33(2):441-63. PMID: 20385346.
      View in: PubMed
    48. Deligiannidis KM. Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. J Clin Psychiatry. 2010 May; 71(5):649-50. PMID: 20492855.
      View in: PubMed
    49. Marsh WK, Deligiannidis KM. Current Psychiatry. Sex-related differences in antidepressant response: When to adjust treatment. 2010; 9(5):25-30.
    50. Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry. 2009 Aug; 66(8):838-47. PMID: 19652123.
      View in: PubMed
    51. Falcón J, Galarneau KM, Weller JL, Ron B, Chen G, Coon SL, Klein DC. Regulation of arylalkylamine N-acetyltransferase-2 (AANAT2, EC in the fish pineal organ: evidence for a role of proteasomal proteolysis. Endocrinology. 2001 May; 142(5):1804-13. PMID: 11316744.
      View in: PubMed
    For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
    Deligiannidis's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description